- 1、本文档共26页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Ebb Tide Win in Chernical - Pharmaceutical Industry 2004 Review and 2005 Trends
PAGE \* MERGEFORMAT 26
Ebb Tide Win in Chernical - Pharmaceutical Industry 2004 Review and 2005 Trends
Sad day, every day too. Looking back on 2004, for the pharmaceutical industry, it is a wet and windy eventful year. In 2005, the pharmaceutical industry are all kinds of unfavorable factors, after a six months. In this writer in the pharmaceutical industry, a number of events in 2004 made some brief review, while the development of the pharmaceutical industry in 2005 made some brief explanation. The level of constraints, it was not exhaustive and hopefully be able to serve as a catalyst enabling us to understand the development of the pharmaceutical industry.
The first part of the pharmaceutical industry in 2004 Review
1, in 2004 the top ten pharmaceutical industry event
1, the three M amp;amp; A events:
A, Yun drug re-acquisition of
Dongsheng through the China Pharmaceutical Industry Co., Ltd. (Dongsheng has its 49% stake), to 750 million in cash entered the cloud medicine, under the restructured agreement, in 2007, cloud Pharmaceutical Group to achieve the sales income of 12.0 billion, net profit of 340 million yuan, paid taxes 1.1 billion. The completion of the acquisition, Mr. Guo Jiaxue Dongsheng, president, said Dongsheng is not in the next five years, acquisition, and the main inner strength!
[Background: In May 1995, Xi’an Dongsheng drinks limited liability company. In December 1996, merger of state-owned enterprises in Shaanxi Dongsheng Pharmaceutical Weidong into the high-tech pharmaceutical sector. In 1999, Dongsheng Group’s expansion westwards, through the buying aluminum shell colleagues to achieve listing, colleagues Aluminum was renamed Topsun Science and Technology. Over the next year or so, the Dongsheng science and technology will be its first electrolytic aluminum assets and Shaanxi Dongsheng Pharmaceutical Co., Ltd. of the bio-pharmaceutical assets replacement, so that science and technology into a bio-pharmaceutical Dongsheng as th
您可能关注的文档
- Early post-stroke patients with dysphagia rehabilitation nursing.doc
- Early post-stroke depression on the prognosis of nursing intervention.doc
- Early observation and nursing of fat embolism.doc
- Early normalization of severe pain in patients with multiple trauma stress response.doc
- Early intervention in the abdomen after surgery medicine disorders of the gastrointestinal_0.doc
- Early onset severe pre-eclampsia incidence analysis of the impact on pregnancy outcome.doc
- Early postoperative chylothorax Observation and nursing care.doc
- Early post-traumatic ocular atrophy Multivariate analysis of risk factors.doc
- Early onset severe preeclampsia expected duration of treatment should be.doc
- Early postoperative care and guidance of esophageal cancer patients.doc
文档评论(0)